← Back to Search

Time Restricted Feeding for Malnutrition

N/A
Recruiting
Led By David Church
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Men and women ages 50-75 years
COVID-19 negative and/or asymptomatic
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours
Awards & highlights

Study Summary

This trial will study how elderly adults respond to different levels of protein intake and different meal patterns.

Who is the study for?
This trial is for men and women aged 50-75 with a BMI of 20-30, who can consent and are COVID-negative/asymptomatic. Excluded are those with low hemoglobin, past GI surgery, hormone therapy users, frequent aspirin users or vigorous exercisers, vegetarians/vegans, certain blood conditions, on blood thinners or steroids, fasting intolerant individuals, diabetics or chronic inflammatory disease sufferers.Check my eligibility
What is being tested?
The study tests how eating patterns affect protein use in the body. Participants will consume meals with two levels of protein intake: the recommended daily amount (0.8g/kg) and double that (1.6g/kg), comparing normal eating schedules to time-restricted feeding where meals are eaten within a specific timeframe each day.See study design
What are the potential side effects?
Since this trial involves dietary changes rather than medication or invasive procedures, side effects may include digestive discomfort due to altered meal timing and potential hunger during fasting periods.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 50 and 75 years old.
Select...
I do not have COVID-19 or any symptoms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Whole-body protein balance

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: TRF of 2RDAExperimental Treatment1 Intervention
A time-restricted model of consumption of twice the RDA of protein/day.
Group II: TRAD of 2RDAExperimental Treatment1 Intervention
A typical American dietary ingestion pattern of twice the RDA of protein/day.
Group III: TRAD of RDAActive Control1 Intervention
A typical American dietary ingestion pattern of the RDA of protein/day.
Group IV: TRF of RDAActive Control1 Intervention
A time-restricted model of consumption of the RDA of protein/day.

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor
486 Previous Clinical Trials
150,293 Total Patients Enrolled
1 Trials studying Malnutrition
68 Patients Enrolled for Malnutrition
David ChurchPrincipal InvestigatorUAMS (University of Arkansas for Medical Sciences)

Media Library

Time Restricted Feeding Clinical Trial Eligibility Overview. Trial Name: NCT05610644 — N/A
Malnutrition Research Study Groups: TRAD of RDA, TRF of 2RDA, TRAD of 2RDA, TRF of RDA
Malnutrition Clinical Trial 2023: Time Restricted Feeding Highlights & Side Effects. Trial Name: NCT05610644 — N/A
Time Restricted Feeding 2023 Treatment Timeline for Medical Study. Trial Name: NCT05610644 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could you provide information about the availability of this research endeavor?

"This medical trial, which was first listed on 3rd of March 2023 and received its last update on the 17th of November 2022, is not currently open for participant recruitment. However, 31 other studies are accepting new enrolments at this time."

Answered by AI

Is my eligibility sufficient to partake in this trial?

"This dietary research is open to men and women aged between 50-75 years old, with a body mass index of 20-30 kg/m2. Furthermore, they must be free from any COVID-19 symptoms or tests results in order to participate and have the capacity to provide informed consent."

Answered by AI

Is the lower age limit for this research younger than 25?

"This study is catering to individuals aged 50-75 years old."

Answered by AI
~8 spots leftby Jul 2024